-
-
-
-
-
-
-
Mizuho defends Immuneering Corporation (IMRX), 'recommend being opportunistic on IMRX'
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Immuneering Corporation (IMRX) following Q4
-
-
-
-
-
-
-
After-hours movers: KB Home, H.B. Fuller, Hertz Global, Immuneering Corporation
-
-
-
-
-
-
-
Immuneering Corporation (IMRX) Tops Q2 EPS by 2c
-
-
-
-
-
-
-
Immuneering Corporation (IMRX) Announces Clinical Supply Agreement with Regeneron Pharmaceuticals to Evaluate IMM-1-104 in Combination with Libtayo
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Immuneering Corporation (IMRX)
-
-
-
456,781 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

